Literature DB >> 18363816

P-selectin polymorphisms' influences on P-selectin serum concentrations and on their familial correlation: the STANISLAS family study.

J B Marteau1, D Lambert, B Herbeth, B Marie, S Droesch, D A Tregouet, S Visvikis-Siest.   

Abstract

BACKGROUND: P-selectin is an adhesion molecule known to be involved in the pathogenesis of several diseases through its major role in the initial phase of leukocytes recruitment during inflammation. However, genetic characterization of soluble P-selectin remains unclear.
OBJECTIVES: In the STANISLAS cohort, we study the familial correlations of P-selectin levels and investigate the association of six P-selectin polymorphisms (C-2123G, A-1969G, S290N, N562D, V599L and T715P) and cardiovascular risk factors with P-selectin concentrations. PATIENTS/
METHODS: Full phenotypic and genotypic information was available for 136 healthy families composed of both natural parents and at least one child (boys, n = 125; and girls, n = 139) aged more than 4 years.
RESULTS: While no correlation was observed between spouses, family correlations of P-selectin concentrations were highly significant for sibling (0.50 +/- 0.12, P < 10(-3)) and child-parent pairs (0.42 +/- 0.04, P < 10(-3)). P-selectin haplotypes explained about 25% of the variability of P-selectin concentrations, this effect being mainly due to the additive effects of two polymorphisms, V599L and T715P. After adjusting for the effect of the P-selectin polymorphisms, the sibling and child-parent correlations decreased to (0.39 +/- 0.08, P < 10(-4)) and (0.32 +/- 0.06, P < 10(-4)), respectively.
CONCLUSIONS: In the present study, we showed that two P-selectin polymorphisms, V599L and T715P, explained about 25% of the variability of P-selectin concentrations and accounted for about 40% of their family resemblance. These results would suggest a genetic influence on P-selectin concentrations beyond the contribution of the P-selectin gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363816     DOI: 10.1111/j.1538-7836.2008.02952.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.

Authors:  J A Heit; J M Cunningham; T M Petterson; S M Armasu; D N Rider; M DE Andrade
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

2.  A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

Authors:  J A Heit; S M Armasu; Y W Asmann; J M Cunningham; M E Matsumoto; T M Petterson; M De Andrade
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

3.  Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Alexander P Reiner; Christopher S Carlson; Bharat Thyagarajan; Mark J Rieder; Joseph F Polak; David S Siscovick; Deborah A Nickerson; David R Jacobs; Myron D Gross
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-05       Impact factor: 8.311

4.  Correlation between P-selectin rs1800807 and rs1800808 Gene polymorphisms and plasma soluble P-selectin concentrations in patients with atrial fibrillation complicated with thromboembolism in Xinjiang, China.

Authors:  Xiaoyun Ma; Hailati Juledezi; Zhiqiang Liu; Wulasihan Muhuyati; Bakeyi Maerjiaen; Pengyi He
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

5.  Putative functional non-coding polymorphisms in SELP significantly modulate sP-selectin levels, arterial stiffness and type 2 diabetes mellitus susceptibility.

Authors:  Raminderjit Kaur; Jatinder Singh; Rohit Kapoor; Manpreet Kaur
Journal:  BMC Endocr Disord       Date:  2020-05-19       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.